268 related articles for article (PubMed ID: 29394493)
21. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle inhibitors for the treatment of NSCLC.
Shcherba M; Liang Y; Fernandes D; Perez-Soler R; Cheng H
Expert Opin Pharmacother; 2014 May; 15(7):991-1004. PubMed ID: 24666387
[TBL] [Abstract][Full Text] [Related]
23. Animal models for modeling pancreatic cancer and novel drug discovery.
Bisht S; Feldmann G
Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in squamous non-small cell lung cancer: evidence beyond predictive biomarkers.
Genova C; Rijavec E; Grossi F
Expert Rev Anticancer Ther; 2016; 16(1):1-4. PubMed ID: 26567561
[TBL] [Abstract][Full Text] [Related]
25. Necitumumab: a new option for first-line treatment of squamous cell lung cancer.
Jiménez Aguilar E; Zugazagoitia Fraile J; Paz-Ares Rodríguez L
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):765-772. PubMed ID: 30025476
[TBL] [Abstract][Full Text] [Related]
26. Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.
Langer CJ; Obasaju C; Bunn P; Bonomi P; Gandara D; Hirsch FR; Kim ES; Natale RB; Novello S; Paz-Ares L; Pérol M; Reck M; Ramalingam SS; Reynolds CH; Socinski MA; Spigel DR; Wakelee H; Mayo C; Thatcher N
J Thorac Oncol; 2016 Dec; 11(12):2066-2081. PubMed ID: 27575423
[TBL] [Abstract][Full Text] [Related]
27. Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Hirsch FR; Kerr KM; Bunn PA; Kim ES; Obasaju C; Pérol M; Bonomi P; Bradley JD; Gandara D; Jett JR; Langer CJ; Natale RB; Novello S; Paz-Ares L; Ramalingam SS; Reck M; Reynolds CH; Smit EF; Socinski MA; Spigel DR; Stinchcombe TE; Vansteenkiste JF; Wakelee H; Thatcher N
Clin Lung Cancer; 2018 Jul; 19(4):331-339. PubMed ID: 29773328
[TBL] [Abstract][Full Text] [Related]
28. Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.
Vari S; Pilotto S; Maugeri-Saccà M; Ciuffreda L; Cesta Incani U; Falcone I; Del Curatolo A; Ceribelli A; Gelibter A; De Maria R; Tortora G; Cognetti F; Bria E; Milella M
Expert Opin Drug Discov; 2013 Nov; 8(11):1381-97. PubMed ID: 24088065
[TBL] [Abstract][Full Text] [Related]
29. The latest animal models of ovarian cancer for novel drug discovery.
Magnotti E; Marasco WA
Expert Opin Drug Discov; 2018 Mar; 13(3):249-257. PubMed ID: 29338446
[TBL] [Abstract][Full Text] [Related]
30. Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy.
Hai J; Zhang H; Zhou J; Wu Z; Chen T; Papadopoulos E; Dowling CM; Pyon V; Pan Y; Liu JB; Bronson RT; Silver H; Lizotte PH; Deng J; Campbell JD; Sholl LM; Ng C; Tsao MS; Thakurdin C; Bass AJ; Wong KK
Clin Cancer Res; 2020 Jul; 26(13):3431-3442. PubMed ID: 32209571
[TBL] [Abstract][Full Text] [Related]
31. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
[TBL] [Abstract][Full Text] [Related]
32. Second-line therapy of squamous non-small cell lung cancer: an evolving landscape.
Lazzari C; Karachaliou N; Gregorc V; Bulotta A; Gonzalez-Cao M; Verlicchi A; Altavilla G; Rosell R; Santarpia M
Expert Rev Respir Med; 2017 Jun; 11(6):469-479. PubMed ID: 28467720
[TBL] [Abstract][Full Text] [Related]
33. Mouse models of lung squamous cell carcinomas.
You MS; Rouggly LC; You M; Wang Y
Cancer Metastasis Rev; 2013 Jun; 32(1-2):77-82. PubMed ID: 23229817
[TBL] [Abstract][Full Text] [Related]
34. Developing EZH2-Targeted Therapy for Lung Cancer.
Frankel AE; Liu X; Minna JD
Cancer Discov; 2016 Sep; 6(9):949-52. PubMed ID: 27587466
[TBL] [Abstract][Full Text] [Related]
35. Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic Alterations.
Jo H; Yagishita S; Hayashi Y; Ryu S; Suzuki M; Kohsaka S; Ueno T; Matsumoto Y; Horinouchi H; Ohe Y; Watanabe SI; Motoi N; Yatabe Y; Mano H; Takahashi K; Hamada A
Mol Cancer Ther; 2022 Feb; 21(2):359-370. PubMed ID: 34911818
[TBL] [Abstract][Full Text] [Related]
36. Innovative Clinical Trials: The LUNG-MAP Study.
Steuer CE; Papadimitrakopoulou V; Herbst RS; Redman MW; Hirsch FR; Mack PC; Ramalingam SS; Gandara DR
Clin Pharmacol Ther; 2015 May; 97(5):488-91. PubMed ID: 25676724
[TBL] [Abstract][Full Text] [Related]
37. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy for NSCLC with driver mutations.
Minuti G; D'Incecco A; Cappuzzo F
Expert Opin Biol Ther; 2013 Oct; 13(10):1401-12. PubMed ID: 23930754
[TBL] [Abstract][Full Text] [Related]
39. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
[TBL] [Abstract][Full Text] [Related]
40. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
